OM1 Stock
HealthTechLooking to sell OM1 stock or options?
Eligible for:
Charitable Exchange Fund
OM1 has developed an outcome management platform that facilitates the measurement, comparison, and prediction of treatment results. This platform collects, synthesizes, enhances, and utilizes clinical data to deliver AI-driven insights and forecasts that can enhance clinical, financial, and operational management. By doing so, it enables healthcare organizations to analyze and apply outcomes data in a clinically meaningful and precise manner.
Investors Include:
Breyer Capital, D1 Capital Partners, 7wire Ventures, General Catalyst, Polaris Partners, Koa Labs, Kaiser Permanente, Wanxiang Healthcare Investments, Scale Venture Partners, Glikvest.